Original Query: ALL
Previous Study | Return to List | Next Study

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02950259
Recruitment Status : Recruiting
First Posted : November 1, 2016
Last Update Posted : December 29, 2017
IRX Therapeutics
Information provided by (Responsible Party):
Providence Health & Services

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2018
  Estimated Study Completion Date : November 2018